These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16843635)
1. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Park IJ; Kim HC; Yu CS; Ryu MH; Chang HM; Kim JH; Ryu JS; Yeo JS; Kim JC Eur J Surg Oncol; 2006 Nov; 32(9):941-7. PubMed ID: 16843635 [TBL] [Abstract][Full Text] [Related]
2. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Valk PE; Abella-Columna E; Haseman MK; Pounds TR; Tesar RD; Myers RW; Greiss HB; Hofer GA Arch Surg; 1999 May; 134(5):503-11; discussion 511-3. PubMed ID: 10323422 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer]. Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351 [TBL] [Abstract][Full Text] [Related]
4. The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. Kalff V; Hicks RJ; Ware RE; Hogg A; Binns D; McKenzie AF J Nucl Med; 2002 Apr; 43(4):492-9. PubMed ID: 11937593 [TBL] [Abstract][Full Text] [Related]
5. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. Kantorová I; Lipská L; Bêlohlávek O; Visokai V; Trubaĉ M; Schneiderová M J Nucl Med; 2003 Nov; 44(11):1784-8. PubMed ID: 14602860 [TBL] [Abstract][Full Text] [Related]
6. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072 [TBL] [Abstract][Full Text] [Related]
7. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer. Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217 [TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma. Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760 [TBL] [Abstract][Full Text] [Related]
9. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Shin SS; Jeong YY; Min JJ; Kim HR; Chung TW; Kang HK Abdom Imaging; 2008; 33(3):270-7. PubMed ID: 17610107 [TBL] [Abstract][Full Text] [Related]
10. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969 [TBL] [Abstract][Full Text] [Related]
11. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Wiering B; Ruers TJ; Krabbe PF; Dekker HM; Oyen WJ Ann Surg Oncol; 2007 Feb; 14(2):818-26. PubMed ID: 17136470 [TBL] [Abstract][Full Text] [Related]
13. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy]. Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869 [TBL] [Abstract][Full Text] [Related]
14. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. Nakamoto Y; Cohade C; Tatsumi M; Hammoud D; Wahl RL Radiology; 2005 Nov; 237(2):627-34. PubMed ID: 16244271 [TBL] [Abstract][Full Text] [Related]
16. PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer. Nagata K; Ota Y; Okawa T; Endo S; Kudo SE Dis Colon Rectum; 2008 Jun; 51(6):882-90. PubMed ID: 18330647 [TBL] [Abstract][Full Text] [Related]
17. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Arulampalam T; Costa D; Visvikis D; Boulos P; Taylor I; Ell P Eur J Nucl Med; 2001 Dec; 28(12):1758-65. PubMed ID: 11734912 [TBL] [Abstract][Full Text] [Related]
18. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level. Lee JH; Park SG; Jee KN; Park DG; Namgung H; Song IH Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474 [TBL] [Abstract][Full Text] [Related]